MedImmune strives to provide better medicines to patients, new medical options for physicians and rewarding careers to employees. Dedicated to advancing science and medicine to help people live better lives, the company is focused on the areas of infectious diseases, cancer and inflammatory diseases. The company has two marketed products and an advancing pipeline of promising candidates, all designed to treat or prevent a number of debilitating or life-threatening diseases.

With ... More >>

Date Title   01/29/10 Pivotal Trial Results for Motavizumab Published in Current Issue of 'Pediatrics' 11/16/09 MedImmune Announces Winners of the 4th Respiratory, Immunology and Autoimmunity Research Abstract Competition 10/30/09 MedImmune to Present Four Abstracts on RSV and Influenza at 47th Annual IDSA Meeting 10/22/09 Interim Clinical Trial Results Show MedImmune's H1N1 Vaccine Has Similar Safety Profile as Seasonal Vaccine in Eligible Children and Adults